Oxford Biomedica Management

Management criteria checks 2/4

Oxford Biomedica's CEO is Frank Mathias, appointed in Mar 2023, has a tenure of 1.67 years. total yearly compensation is £520.00K, comprised of 88.1% salary and 11.9% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth £81.99K. The average tenure of the management team and the board of directors is 1.2 years and 3.7 years respectively.

Key information

Frank Mathias

Chief executive officer

UK£520.0k

Total compensation

CEO salary percentage88.1%
CEO tenure1.7yrs
CEO ownership0.02%
Management average tenure1.2yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oct 19
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Aug 23
Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 15
Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Oct 06
Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

May 02
Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

Jun 29
We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

CEO Compensation Analysis

How has Frank Mathias's remuneration changed compared to Oxford Biomedica's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-UK£142m

Mar 31 2024n/an/a

-UK£150m

Dec 31 2023UK£520kUK£458k

-UK£157m

Compensation vs Market: Frank's total compensation ($USD655.55K) is below average for companies of similar size in the UK market ($USD1.02M).

Compensation vs Earnings: Insufficient data to compare Frank's compensation with company performance.


CEO

Frank Mathias (62 yo)

1.7yrs

Tenure

UK£520,000

Compensation

Dr. Frank Mathias is Chief Executive Officer and Director of Oxford Biomedica plc from March 27, 2023. Dr. Mathias was the Chief Executive Officer of Rentschler Biopharma SE from April 2016 until March 202...


Leadership Team

NamePositionTenureCompensationOwnership
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
£ 81.8k
Lucinda Crabtree
CFO & Directorless than a yearno datano data
Thierry Cournez
Chief Operating Officer1.1yrsno datano data
Sophia Bolhassan
Head of Investor Relationsno datano datano data
Natalie Walter
General Counsel & Company Secretary5.5yrsno datano data
Lisa James
Chief People Officer2.6yrsno datano data
Kyriacos Mitrophanous
Chief Innovation Officerless than a yearno datano data
Kati Hudson
Head of Intellectual Property and Contractsno datano datano data
Sebastien Ribault
Chief Business Officer2yrsno datano data
Mark Caswell
Site Head of UK Operations1.3yrsno datano data
Stephanie Colloud
Site Head & GM of France Operationsless than a yearno datano data
Sabine Sydow
Chief of Staffless than a yearno datano data

1.2yrs

Average Tenure

51yo

Average Age

Experienced Management: OXB's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
£ 81.8k
Lucinda Crabtree
CFO & Directorless than a yearno datano data
Frederic Doliveux
Non-Executive Chair4.4yrsUK£225.00k0.35%
£ 1.5m
William Langston
Member of Scientific Advisory Boardno datano datano data
Peter Stern
Member of Scientific Advisory Boardno datano datano data
Krystof Bankiewicz
Member of Scientific Advisory Boardno datano datano data
Leone Patterson
Independent Non-Executive Director1.5yrsUK£87.00k0.012%
£ 50.9k
Heather Preston
Independent Non-Executive Director6.7yrsUK£140.00k0.017%
£ 74.9k
Dame Davies
Senior Independent Director3.7yrsUK£73.00k0.00095%
£ 4.1k
Stuart Henderson
Independent Vice Chair8.4yrsUK£85.00k0.010%
£ 44.4k
Robert Ghenchev
Non-Executive Director5.4yrsno datano data
Namrata Patel
Independent Non-Executive Director2.6yrsUK£65.00k0.0087%
£ 37.5k

3.7yrs

Average Tenure

62yo

Average Age

Experienced Board: OXB's board of directors are considered experienced (3.7 years average tenure).